Researchers have identified the first genetic variation that is associated with increased risk and severity of peripheral neuropathy following treatment with a widely used anti-cancer drug.

Major depressive disorders rank among the top five diseases with the highest global burden in North America and Europe (Murray et al, 2012). Although pharmacological treatments exist, several trials ...

Damage to the peripheral nerves can affect their signaling, resulting in various painful or otherwise unusual sensations, known as peripheral neuropathy. Lifetyle changes, and addressing the ...

Estimating clear cell renal cell carcinoma transcriptomic signatures using machine learning and histopathology images. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...

Effect of coadministration of statins on neutropenia in a phase I genotype-directed dose-escalation study of irinotecan. Background: CALGB 40101 is an ongoing phase III trial comparing the efficacy of ...